Suppr超能文献

肾再移植结局:配对受者对照研究。

Kidney Retransplantation Outcomes: A Paired Recipient Control Study.

机构信息

Nephrology Department, Coimbra University Hospital Center, Coimbra, Portugal.

Nephrology Department, Coimbra University Hospital Center, Coimbra, Portugal; Nephrology Clinic, Faculty of Medicine, University of Coimbra, Coimbra, Portugal.

出版信息

Transplant Proc. 2022 Jun;54(5):1236-1241. doi: 10.1016/j.transproceed.2022.04.005. Epub 2022 May 25.

Abstract

BACKGROUND

Despite progressive improvements in graft and patient survival after kidney transplantation over the last decades, an increasing number of patients are waitlisted for retransplantation. Identifying the risk factors for second graft failure can help us improve management for such patients. The aim of this study was to compare the outcomes of kidney retransplantation with those of first transplantation.

METHODS

This retrospective study included all the recipients of a second kidney transplant between January 2008 and December 2019. For each patient with a second kidney transplant, we selected the paired recipient from the same donor. We excluded recipients of donations from living donors, patient-and-donor pairs with more than 1 transplant, and patients without a pair. The follow-up took place December 31, 2020. We included 152 patients, corresponding to 76 pairs of recipients.

RESULTS

Patients who underwent a second transplant had significantly higher panel reactive antibody values and longer waiting time for retransplantation. Biopsy-proven acute rejection episodes were doubled in patients undergoing a second transplant (P = .12). There was a lower survival of second grafts at the first, fifth, and 10th year (P < .05). The main factor influencing graft loss for both groups was acute rejection, and, in patients, with a second transplant, acute rejection increased the risk of graft loss by 17 times (odds ratio, 17.5; 95% confidence interval, 4.19-98).

CONCLUSIONS

The clinical results of second kidney transplants still fall short of first transplants, with the main factor of poor prognosis being acute rejection. In young patients, allocation and immunosuppression management should consider this risk to improve long-term outcomes.

摘要

背景

尽管在过去几十年中,肾移植后移植物和患者存活率都有所提高,但越来越多的患者需要等待再次移植。确定导致第二次移植物失败的风险因素有助于我们改善此类患者的管理。本研究的目的是比较肾再移植与首次移植的结果。

方法

本回顾性研究纳入了 2008 年 1 月至 2019 年 12 月期间接受第二次肾移植的所有受者。对于每一位接受第二次肾移植的患者,我们都从同一供体中选择配对的受者。我们排除了活体供者供肾的受者、接受超过 1 次移植的患者-供者对以及没有配对的患者。随访截止日期为 2020 年 12 月 31 日。我们纳入了 152 名患者,共 76 对受者。

结果

接受第二次移植的患者群体的群体反应性抗体值明显更高,且等待再次移植的时间更长。第二次移植的患者活检证实的急性排斥反应发生率增加了一倍(P =.12)。第二次移植的移植物在第 1、5 和 10 年的存活率较低(P <.05)。影响两组移植物丢失的主要因素是急性排斥反应,在接受第二次移植的患者中,急性排斥反应使移植物丢失的风险增加了 17 倍(比值比,17.5;95%置信区间,4.19-98)。

结论

第二次肾移植的临床结果仍不如首次移植,导致预后不良的主要因素是急性排斥反应。在年轻患者中,配型和免疫抑制管理应考虑到这一风险,以改善长期结果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验